BR1100889A - Proteìna hìbrida, sequência de dna, vetor, hospedeiro, partìcula de lipoproteìna multimérica, vacina, uso da vacina e processos de produção de proteìnas hìbridas e partìculas - Google Patents

Proteìna hìbrida, sequência de dna, vetor, hospedeiro, partìcula de lipoproteìna multimérica, vacina, uso da vacina e processos de produção de proteìnas hìbridas e partìculas

Info

Publication number
BR1100889A
BR1100889A BR1100889-0A BR1100889A BR1100889A BR 1100889 A BR1100889 A BR 1100889A BR 1100889 A BR1100889 A BR 1100889A BR 1100889 A BR1100889 A BR 1100889A
Authority
BR
Brazil
Prior art keywords
hybrid
vaccine
particle
protein
vector
Prior art date
Application number
BR1100889-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Michel De Wilde
Joseph Cohen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to BR1100889-0A priority Critical patent/BR1100889A/pt
Publication of BR1100889A publication Critical patent/BR1100889A/pt

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
BR1100889-0A 1991-11-16 1997-05-14 Proteìna hìbrida, sequência de dna, vetor, hospedeiro, partìcula de lipoproteìna multimérica, vacina, uso da vacina e processos de produção de proteìnas hìbridas e partìculas BR1100889A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR1100889-0A BR1100889A (pt) 1991-11-16 1997-05-14 Proteìna hìbrida, sequência de dna, vetor, hospedeiro, partìcula de lipoproteìna multimérica, vacina, uso da vacina e processos de produção de proteìnas hìbridas e partìculas

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919124390A GB9124390D0 (en) 1991-11-16 1991-11-16 Vaccines
BR1100889-0A BR1100889A (pt) 1991-11-16 1997-05-14 Proteìna hìbrida, sequência de dna, vetor, hospedeiro, partìcula de lipoproteìna multimérica, vacina, uso da vacina e processos de produção de proteìnas hìbridas e partìculas

Publications (1)

Publication Number Publication Date
BR1100889A true BR1100889A (pt) 2005-06-21

Family

ID=10704755

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100889-0A BR1100889A (pt) 1991-11-16 1997-05-14 Proteìna hìbrida, sequência de dna, vetor, hospedeiro, partìcula de lipoproteìna multimérica, vacina, uso da vacina e processos de produção de proteìnas hìbridas e partìculas

Country Status (4)

Country Link
BR (1) BR1100889A (OSRAM)
GB (1) GB9124390D0 (OSRAM)
TW (1) TW247320B (OSRAM)
ZA (1) ZA928770B (OSRAM)

Also Published As

Publication number Publication date
ZA928770B (en) 1994-05-13
TW247320B (OSRAM) 1995-05-11
GB9124390D0 (en) 1992-01-08

Similar Documents

Publication Publication Date Title
FI963246A7 (fi) Geeniterapiassa käytettävä isäntävektorijärjestelmä
FI933580A7 (fi) Pneumokokkiproteiinin rakennegeeni
FI974429L (fi) Suspendoituja peptidi/proteiinivalmisteita
FI943389L (fi) Bacillus-lajista saatu ksylanaasi, tällaisen ksylanaasin ja muiden proteiinien ekspressiovektori, niiden isäntäorganismit ja käyttö
NO20001240D0 (no) Kay-A immunsystemprotein
FI970656A0 (fi) Painonsäätelyaineet, vastaavat nukseiinihapot ja proteiinit ja näiden diagnostiset ja terapeuttiset käytöt
PL309403A1 (en) Modified cutinases, dna, vector and host
FI943591A7 (fi) Synteettinen hemofilus-influenssa yhdistelmärokote
ATE184052T1 (de) Gdf-1 und uog1 proteine
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
DE69929612D1 (de) Purifikation von viruspräparaten
AU6713894A (en) Natural or recombinant dna binding proteins as carriers for gene transfer or gene therapy
FI962247L (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
DK0918059T3 (da) Susbstituerede imidazolidinderivater, deres fremstilling og anvendelse samt farmaceutiske præparater indeholdende disse derivater
ZA974574B (en) Novel guanidine derivatives process for their preparations and their use as pharmaceuticals.
FI963781A7 (fi) Eristettyjä, MAGE-3-peräisiä peptidejä, jotka kompleksoivat HLA-A2-mol ekyylejä, ja niiden käyttöjä
ZA9610721B (en) Grapevine leafroll virus proteins and their uses.
AU1324192A (en) Process for electroelution of a gel containing separated charged macromolecules, such as proteins or DNA/RNA, and an apparatus and means for use in the process
HUP9801266A3 (en) Multimeric, recombinant urease vaccine
PL309388A1 (en) Modified cutinases, dna, vector and host
EP0481072A4 (en) Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines
NO983464D0 (no) Buffersystemer for stabilisering av farmas°ytiske preparater
ZA976967B (en) Device and process for separating magnetic materials from pharmaceutical preparations, their starting or intermediate products, as well as agents that are produced with the of said device.
NO963487D0 (no) Isolerte, tyrosinaseavledete peptider, samt anvendelser derav
AU4090393A (en) Fowl mycoplasma antigen, gene thereof, recombinant vector containing said gene, and vaccine prepared by utilizing the same